Literature DB >> 15951967

Referrals of patients to colorectal cancer genetics services in south-east Scotland.

Susan Holloway1, Mary Porteous, Roseanne Cetnarskyj, Robert Rush, Sally Appleton, Dermot Gorman, Harry Campbell.   

Abstract

The discovery that genetic factors are involved in the aetiology of colorectal cancer, has prompted many relatives of affected individuals to seek genetic counselling and screening. This paper describes the demand for genetic services by families with colorectal cancer in south-east Scotland, their expectations and views of the service offered. The annual referral rate over the 21-month study period, for patients with a family history of colorectal cancer, was 0.11 per 1000 patients on general practitioner lists. This is one third of the rate for patients with a family history of breast cancer and in comparison with the breast cancer group, relatives of colorectal cancer patients were significantly older and less socially deprived. Approximately one third were referred via a hospital specialist unit. One hundred patients were included in the study. Mean (+/- standard deviation) age was 43 (+/- 10.7 years), 75 were female and 31 were self referrals. Before the consultation, almost half the patients had an inflated perception of their risk and there was little change at follow-up. There was an improvement in objective understanding after counselling which was sustained up to 6 months but only two thirds remembered their objective risk accurately. Most patients were satisfied with the consultation. Our findings suggest the need to educate individuals, in particular men, younger people and the more socially deprived, about the relevance of a family history of colorectal cancer and to facilitate patients' comprehension of their risk status.

Entities:  

Mesh:

Year:  2005        PMID: 15951967     DOI: 10.1007/s10689-004-4488-y

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  24 in total

1.  Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer.

Authors:  K Nordin; A Lidén; M Hansson; R Rosenquist; G Berglund
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

Review 2.  Genetic testing and counseling for hereditary forms of colorectal cancer.

Authors:  G M Petersen; J D Brensinger; K A Johnson; F M Giardiello
Journal:  Cancer       Date:  1999-12-01       Impact factor: 6.860

3.  Deprivation and health in Scotland.

Authors:  V Carstairs; R Morris
Journal:  Health Bull (Edinb)       Date:  1990-07

4.  Family history of breast cancer: what do women understand and recall about their genetic risk?

Authors:  M Watson; V Duvivier; M Wade Walsh; S Ashley; J Davidson; M Papaikonomou; V Murday; N Sacks; R Eeles
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

5.  Genetic testing for colorectal carcinoma susceptibility: focus group responses of individuals with colorectal carcinoma and first-degree relatives.

Authors:  A Y Kinney; B M DeVellis; C Skrzynia; R Millikan
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

6.  Accuracy of reporting of family history of colorectal cancer.

Authors:  R J Mitchell; D Brewster; H Campbell; M E M Porteous; A H Wyllie; C C Bird; M G Dunlop
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

7.  Referrals of women with a family history of breast cancer from primary care to cancer genetics services in South East Scotland.

Authors:  H Campbell; S Holloway; R Cetnarskyj; E Anderson; R Rush; A Fry; D Gorman; M Steel; M Porteous
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

8.  Patient satisfaction with two different models of cancer genetic services in south-east Scotland.

Authors:  S Holloway; M Porteous; R Cetnarskyj; E Anderson; R Rush; A Fry; D Gorman; M Steel; H Campbell
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

9.  A cross-sectional survey to estimate the prevalence of family history of colorectal, breast and ovarian cancer in a Scottish general practice population.

Authors:  E Wallace; A Hinds; H Campbell; J Mackay; R Cetnarskyj; M E M Porteous
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

10.  A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact.

Authors:  A Fry; A Cull; S Appleton; R Rush; S Holloway; D Gorman; R Cetnarskyj; R Thomas; J Campbell; E Anderson; M Steel; M Porteous; H Campbell
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

View more
  5 in total

1.  Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia.

Authors:  T G W Letteboer; J J Mager; R J Snijder; B P C Koeleman; D Lindhout; J K Ploos van Amstel; C J J Westermann
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

2.  Cancer genetic predisposition: information needs of patients irrespective of risk level.

Authors:  Alison Metcalfe; Julie Werrett; Lucy Burgess; Cyril Chapman; Collette Clifford
Journal:  Fam Cancer       Date:  2009-06-11       Impact factor: 2.375

3.  Inequality of use of cancer genetics services by members of breast, ovarian and colorectal cancer families in South East Scotland.

Authors:  Susan M Holloway; Birgitta Bernhard; Harry Campbell; Roseanne Cetnarskyj; Wayne W K Lam
Journal:  Fam Cancer       Date:  2008-02-02       Impact factor: 2.375

4.  Reflex testing for Lynch syndrome: if we build it, will they come? Lessons learned from the uptake of clinical genetics services by individuals with newly diagnosed colorectal cancer (CRC).

Authors:  E Tomiak; A Samson; N Spector; M Mackey; C Gilpin; E Smith; D Jonker; J Allanson; T Asmis
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

5.  Risk perception after genetic counseling in patients with increased risk of cancer.

Authors:  Johanna Rantala; Ulla Platten; Gunilla Lindgren; Bo Nilsson; Brita Arver; Annika Lindblom; Yvonne Brandberg
Journal:  Hered Cancer Clin Pract       Date:  2009-08-23       Impact factor: 2.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.